Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: Functional impact in controlling CMV-infected dendritic cells

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2708-2716

  Djaoud, Zakia ^a   David, Gaëlle ^a   Bressollette, Céline ^b   Willem, Catherine ^a   Rettman, Pauline ^a   Gagne, Katia ^a,c   Legrand, Nolwenn ^a   Mehlal, Souad ^a   Cesbron, Anne ^a,c   Imbert Marcille, Berthe Marie ^b   Retière, Christelle ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c LabEx Transplantex   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2C; UNCLASSIFIED DRUG;

ADULT; ALLOIMMUNITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CELL MATURATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE EVASION; INFECTION CONTROL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

CYTOMEGALOVIRUS INFECTIONS; DENDRITIC CELLS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, KIR; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL3;

EID: 84883443483     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301138     Document Type: Article

References (47)

1. Biron, C. A., H. C. Su, and J. S. Orange. 1996. Function and regulation of natural killer (NK) cells during viral infections: characterization of responses in vivo. Methods 9: 379-393.
2. Kärre, K. 2002. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55: 221-228.
3. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Söderström, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799.
4. Moretta, L., and A. Moretta. 2004. Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16: 626-633.
5. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
6. Yewdell, J.W., and A. B. Hill. 2002. Viral interference with antigen presentation. Nat. Immunol. 3: 1019-1025.
7. Wilkinson, G. W. G., P. Tomasec, R. J. Stanton, M. Armstrong, V. Prod'homme, R. Aicheler, B. P. McSharry, C. R. Rickards, D. Cochrane, S. Llewellyn-Lacey, et al. 2008. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41: 206-212.
8. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
9. + natural killer cells with potent function. Blood 119: 2665-2674.
10. + NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42: 447-457.
11. Béziat, V., L. L. Liu, J.-A. Malmberg, M. A. Ivarsson, E. Sohlberg, A. T. Björklund, C. Retière, E. Sverremark-Ekström, J. Traherne, P. Ljungman, et al. 2013. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121: 2678-2688.
12. Charoudeh, H. N., G. Terszowski, K. Czaja, A. Gonzalez, K. Schmitter, and M. Stern. 2013. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Eur. J. Immunol. 43: 480-487.
13. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273-282.
14. Kubin, M., L. Cassiano, J. Chalupny, W. Chin, D. Cosman, W. Fanslow, J. Müllberg, A. M. Rousseau, D. Ulrich, and R. Armitage. 2001. ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur. J. Immunol. 31: 1428-1437.
15. Babić, M., A. Krmpotić, and S. Jonjić. 2011. All is fair in virus-host interactions: NK cells and cytomegalovirus. Trends Mol. Med. 17: 677-685.
16. Stern, M., H. Elsässer, G. Hönger, J. Steiger, S. Schaub, and C. Hess. 2008. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients. Am. J. Transplant. 8: 1312-1317.
17. Cook, M., D. Briggs, C. Craddock, P. Mahendra, D. Milligan, C. Fegan, P. Darbyshire, S. Lawson, E. Boxall, and P. Moss. 2006. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following Tcell replete stem cell transplantation. Blood 107: 1230-1232.
18. Chen, C., M. Busson, V. Rocha, M.-L. Appert, V. Lepage, N. Dulphy, P. Haas, G. Socié, A. Toubert, D. Charron, and P. Loiseau. 2006. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant. 38: 437-444.
19. Della Chiesa, M., M. Falco, M. Podestà, F. Locatelli, L. Moretta, F. Frassoni, and A. Moretta. 2012. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 119: 399-410.
20. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
21. Marsh, S. G. E., P. Parham, B. Dupont, D. E. Geraghty, J. Trowsdale, D. Middleton, C. Vilches, M. Carrington, C. Witt, L. A. Guethlein, et al. 2003. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 62: 79-86.
22. Denis, L., J. Sivula, P.-A. Gourraud, N. Kerdudou, R. Chout, C. Ricard, J.-P. Moisan, K. Gagne, J. Partanen, and J.-D. Bignon. 2005. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion. Tissue Antigens 66: 267-276.
23. Repnik, U., M. Knezevic, and M. Jeras. 2003. Simple and cost-effective isolation of monocytes from buffy coats. J. Immunol. Methods 278: 283-292.
24. + NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells. J. Immunol. 182: 6727-6735.
25. Morvan, M., G. David, V. Sébille, A. Perrin, K. Gagne, C. Willem, N. Kerdudou, L. Denis, B. Clémenceau, G. Folléa, et al. 2008. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Eur. J. Immunol. 38: 3474-3486.
26. Garrett, J. S., J. C. Narus, J. F. Bohnsack, D. E. Carling, K. G. Grieves, W. J. Waldman, and R. E. Shaddy. 1995. Effects of cytomegalovirus infection on growth factor production in endothelial cells and fibroblasts. Pediatr. Res. 38: 1003-1008.
27. David, G., M. Morvan, K. Gagne, N. Kerdudou, C. Willem, A. Devys, M. Bonneville, G. Folléa, J.-D. Bignon, and C. Retière. 2009. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology 128: 172-184.
28. Imbert-Marcille, B. M., N. Robillard, A. S. Poirier, M. Coste-Burel, D. Cantarovich, N. Milpied, and S. Billaudel. 1997. Development of a method for direct quantification of cytomegalovirus antigenemia by flow cytometry. J. Clin. Microbiol. 35: 2665-2669.
29. Riegler, S., H. Hebart, H. Einsele, P. Brossart, G. Jahn, and C. Sinzger. 2000. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 81: 393-399.
30. Moutaftsi, M., A. M. Mehl, L. K. Borysiewicz, and Z. Tabi. 2002. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99: 2913-2921.
31. Orr, M. T., W. J. Murphy, and L. L. Lanier. 2010. "Unlicensed" natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 11: 321-327.
32. Moesta, A. K., P. J. Norman, M. Yawata, N. Yawata, M. Gleimer, and P. Parham. 1950. 2008. Synergistic polymorphism at two positions distal to the ligandbinding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 180: 3969-3979.
33. Pende, D., S. Marcenaro, M. Falco, S. Martini, M. E. Bernardo, D. Montagna, E. Romeo, C. Cognet, M. Martinetti, R. Maccario, et al. 2009. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113: 3119-3129.
34. Schönberg, K., M. Sribar, J. Enczmann, J. C. Fischer, and M. Uhrberg. 2011. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 117: 98-107.
35. Kuijpers, T. W., P. A. Baars, C. Dantin, M. van den Burg, R. A. W. van Lier, and E. Roosnek. 2008. Human NK cells can control CMV infection in the absence of T cells. Blood 112: 914-915.
36. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
37. Carrington, M., M. P. Martin, and J. van Bergen. 2008. KIR-HLA intercourse in HIV disease. Trends Microbiol. 16: 620-627.
38. Sivori, S., S. Carlomagno, M. Falco, E. Romeo, L. Moretta, and A. Moretta. 2011. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT. Blood 117: 4284-4292.
39. Brackenridge, S., E. J. Evans, M. Toebes, N. Goonetilleke, M. K. P. Liu, K. di Gleria, T. N. Schumacher, S. J. Davis, A. J. McMichael, and G. M. Gillespie. 2011. An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. J. Virol. 85: 5415-5422.
40. Stewart-Jones, G. B. E., K. di Gleria, S. Kollnberger, A. J. McMichael, E. Y. Jones, and P. Bowness. 2005. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur. J. Immunol. 35: 341-351.
41. Fadda, L., G. M. O'Connor, S. Kumar, A. Piechocka-Trocha, C. M. Gardiner, M. Carrington, D. W. McVicar, and M. Altfeld. 2011. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J. Virol. 85: 5970-5974.
42. Hansasuta, P., T. Dong, H. Thananchai, M. Weekes, C. Willberg, H. Aldemir, S. Rowland-Jones, and V. M. Braud. 2004. Recognition of HLA-A3 and HLAA11 by KIR3DL2 is peptide-specific. Eur. J. Immunol. 34: 1673-1679.
43. Alter, G., D. Heckerman, A. Schneidewind, L. Fadda, C. M. Kadie, J. M. Carlson, C. Oniangue-Ndza, M. Martin, B. Li, S. I. Khakoo, et al. 2011. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476: 96-100.
44. hi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725-14732.
45. Björkström, N. K., T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaëlsson, K.-J. Malmberg, J. Klingström, C. Ahlm, and H.-G. Ljunggren. 2011. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208: 13-21.
46. Petitdemange, C., P. Becquart, N. Wauquier, V. Béziat, P. Debré, E. M. Leroy, and V. Vieillard. 2011. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 7: e1002268.
47. Gumá, M., C. Cabrera, I. Erkizia, M. Bofill, B. Clotet, L. Ruiz, and M. López-Botet. 2006. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194: 38-41.